Selected research
Industry Research
Calcitonin Injection Industry Research Report 2026
Market perspective
The global Calcitonin Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Calcitonin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Calcitonin Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Calcitonin Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Calcitonin Injection include Yingu, Shanghai No.1 Bio, Qingdao Guoda, Novartis, Guilin Pharma, Chengdu List Pharma, Lisapharma, Hybio Pharmaceutical and Guoda Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Calcitonin Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Calcitonin Injection Market by Company
Yingu
Shanghai No.1 Bio
Qingdao Guoda
Novartis
Guilin Pharma
Chengdu List Pharma
Lisapharma
Hybio Pharmaceutical
Guoda Bio
Future Health Pharma
DAPHAE
CSPC
Asahi Kasei Pharma
Calcitonin Injection Segment by Type
Elcatonin Injection
Salmon Calcitonin Injection
Calcitonin Injection Segment by Application
Hospital
Clinic
Calcitonin Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calcitonin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calcitonin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calcitonin Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Calcitonin Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Calcitonin Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Calcitonin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Elcatonin Injection
- Salmon Calcitonin Injection
Applications
- Hospital
- Clinic
Companies covered
- Yingu
- Shanghai No.1 Bio
- Qingdao Guoda
- Novartis
- Guilin Pharma
- Chengdu List Pharma
- Lisapharma
- Hybio Pharmaceutical
- Guoda Bio
- Future Health Pharma
- DAPHAE
- CSPC
- Asahi Kasei Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Calcitonin Injection Market Size (2021-2032)
- 2.2.2 Global Calcitonin Injection Sales (2021-2032)
- 2.2.3 Global Calcitonin Injection Market Average Price (2021-2032)
- 2.3 Calcitonin Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Elcatonin Injection
- 2.3.3 Salmon Calcitonin Injection
- 2.4 Calcitonin Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Calcitonin Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Calcitonin Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Calcitonin Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Calcitonin Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Calcitonin Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Calcitonin Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Calcitonin Injection, Product Type & Application
- 3.8 Global Manufacturers of Calcitonin Injection, Established Date
- 3.9 Global Calcitonin Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yingu
- 4.1.1 Yingu Company Information
- 4.1.2 Yingu Business Overview
- 4.1.3 Yingu Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yingu Calcitonin Injection Product Portfolio
- 4.1.5 Yingu Recent Developments
- 4.2 Shanghai No.1 Bio
- 4.2.1 Shanghai No.1 Bio Company Information
- 4.2.2 Shanghai No.1 Bio Business Overview
- 4.2.3 Shanghai No.1 Bio Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai No.1 Bio Calcitonin Injection Product Portfolio
- 4.2.5 Shanghai No.1 Bio Recent Developments
- 4.3 Qingdao Guoda
- 4.3.1 Qingdao Guoda Company Information
- 4.3.2 Qingdao Guoda Business Overview
- 4.3.3 Qingdao Guoda Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qingdao Guoda Calcitonin Injection Product Portfolio
- 4.3.5 Qingdao Guoda Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Calcitonin Injection Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Guilin Pharma
- 4.5.1 Guilin Pharma Company Information
- 4.5.2 Guilin Pharma Business Overview
- 4.5.3 Guilin Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guilin Pharma Calcitonin Injection Product Portfolio
- 4.5.5 Guilin Pharma Recent Developments
- 4.6 Chengdu List Pharma
- 4.6.1 Chengdu List Pharma Company Information
- 4.6.2 Chengdu List Pharma Business Overview
- 4.6.3 Chengdu List Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chengdu List Pharma Calcitonin Injection Product Portfolio
- 4.6.5 Chengdu List Pharma Recent Developments
- 4.7 Lisapharma
- 4.7.1 Lisapharma Company Information
- 4.7.2 Lisapharma Business Overview
- 4.7.3 Lisapharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lisapharma Calcitonin Injection Product Portfolio
- 4.7.5 Lisapharma Recent Developments
- 4.8 Hybio Pharmaceutical
- 4.8.1 Hybio Pharmaceutical Company Information
- 4.8.2 Hybio Pharmaceutical Business Overview
- 4.8.3 Hybio Pharmaceutical Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hybio Pharmaceutical Calcitonin Injection Product Portfolio
- 4.8.5 Hybio Pharmaceutical Recent Developments
- 4.9 Guoda Bio
- 4.9.1 Guoda Bio Company Information
- 4.9.2 Guoda Bio Business Overview
- 4.9.3 Guoda Bio Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Guoda Bio Calcitonin Injection Product Portfolio
- 4.9.5 Guoda Bio Recent Developments
- 4.10 Future Health Pharma
- 4.10.1 Future Health Pharma Company Information
- 4.10.2 Future Health Pharma Business Overview
- 4.10.3 Future Health Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Future Health Pharma Calcitonin Injection Product Portfolio
- 4.10.5 Future Health Pharma Recent Developments
- 4.11 DAPHAE
- 4.11.1 DAPHAE Company Information
- 4.11.2 DAPHAE Business Overview
- 4.11.3 DAPHAE Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 DAPHAE Calcitonin Injection Product Portfolio
- 4.11.5 DAPHAE Recent Developments
- 4.12 CSPC
- 4.12.1 CSPC Company Information
- 4.12.2 CSPC Business Overview
- 4.12.3 CSPC Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CSPC Calcitonin Injection Product Portfolio
- 4.12.5 CSPC Recent Developments
- 4.13 Asahi Kasei Pharma
- 4.13.1 Asahi Kasei Pharma Company Information
- 4.13.2 Asahi Kasei Pharma Business Overview
- 4.13.3 Asahi Kasei Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Asahi Kasei Pharma Calcitonin Injection Product Portfolio
- 4.13.5 Asahi Kasei Pharma Recent Developments
5 Global Calcitonin Injection Market Scenario by Region
- 5.1 Global Calcitonin Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Calcitonin Injection Sales by Region: 2021-2032
- 5.2.1 Global Calcitonin Injection Sales by Region: 2021-2026
- 5.2.2 Global Calcitonin Injection Sales by Region: 2027-2032
- 5.3 Global Calcitonin Injection Revenue by Region: 2021-2032
- 5.3.1 Global Calcitonin Injection Revenue by Region: 2021-2026
- 5.3.2 Global Calcitonin Injection Revenue by Region: 2027-2032
- 5.4 North America Calcitonin Injection Market Facts & Figures by Country
- 5.4.1 North America Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Calcitonin Injection Sales by Country (2021-2032)
- 5.4.3 North America Calcitonin Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Calcitonin Injection Market Facts & Figures by Country
- 5.5.1 Europe Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Calcitonin Injection Sales by Country (2021-2032)
- 5.5.3 Europe Calcitonin Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Calcitonin Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Calcitonin Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Calcitonin Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Calcitonin Injection Market Facts & Figures by Country
- 5.7.1 South America Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Calcitonin Injection Sales by Country (2021-2032)
- 5.7.3 South America Calcitonin Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Calcitonin Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Calcitonin Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Calcitonin Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Calcitonin Injection Sales by Type (2021-2032)
- 6.1.1 Global Calcitonin Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Calcitonin Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Calcitonin Injection Revenue by Type (2021-2032)
- 6.2.1 Global Calcitonin Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Calcitonin Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Calcitonin Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Calcitonin Injection Sales by Application (2021-2032)
- 7.1.1 Global Calcitonin Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Calcitonin Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Calcitonin Injection Revenue by Application (2021-2032)
- 7.2.1 Global Calcitonin Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Calcitonin Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Calcitonin Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Calcitonin Injection Value Chain Analysis
- 8.1.1 Calcitonin Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Calcitonin Injection Production Mode & Process
- 8.2 Calcitonin Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Calcitonin Injection Distributors
- 8.2.3 Calcitonin Injection Customers
9 Global Calcitonin Injection Analyzing Market Dynamics
- 9.1 Calcitonin Injection Industry Trends
- 9.2 Calcitonin Injection Industry Drivers
- 9.3 Calcitonin Injection Industry Opportunities and Challenges
- 9.4 Calcitonin Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst